{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:00Z","timestamp":1787071020971,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aims to evaluate the efficacy, feasibility, tolerability, and toxicity of concurrent chemotherapy and brachytherapy for locally advanced cervical carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      Forty patients of cervical carcinoma were included in this study. The study period ranges from October 2016 to September 2019. Patients were evaluated and treated as per the protocol: external beam radiotherapy (50 Gy in 25 fractions) and concurrent weekly chemotherapy with injection (Inj.) cisplatin (30 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) followed by high-dose rate brachytherapy (3 fractions of 7 Gy each) and concurrent chemotherapy Inj. cisplatin (30 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 40 patients enrolled in the study, 36 patients completed the treatment (17 Stage II and 19 Stage III). The incidence of Grade I and II skin toxicities were 78% and 10%, respectively. The incidence of genitourinary toxicities with respect to Grade I and II were 72% and 12%, respectively. There were Grade III hematological toxicities in two patients and the brachytherapy treatment was delayed for 4\u20136 days. The overall complete response was found in 28 (78%) patients, partial response in six (16.7%) patients, and progressive disease in two (5.6%) patients at 3 months of follow-up. On the last follow-up, 21 (58%) patients were disease-free and there was disease failure in seven patients (5 local recurrence and 2 with distant metastasis).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Brachytherapy with the addition of concurrent chemotherapy is effective and feasible with acceptable toxicity for advanced stages of carcinoma cervix. This study upholds an interesting approach that can be regarded as feasible and tolerable for cervical cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_507_20","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T05:09:21Z","timestamp":1629263361000},"page":"1572-1577","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Concurrent chemotherapy with high-dose rate brachytherapy after treatment with chemoradiotherapy in cases of locally advanced carcinoma cervix"],"prefix":"10.4103","volume":"18","author":[{"given":"Vandana Shailendra","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuresh","family":"Virkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukund B.","family":"Sarje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitali M.","family":"Waghmare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanandan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Mohan","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20241021","first-page":"219","article-title":"The magnitude of cancer cervix in India","volume":"130","author":"Nandakumar","year":"2009","journal-title":"Indian J Med Res"},{"key":"R3-20-20241021","first-page":"1","article-title":"Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"0","author":"Freddie","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R4-20-20241021","first-page":"43","article-title":"Patterns of failure in cervical carcinoma and outcome of salvage therapy: A retrospective study","volume":"1","author":"Vasishta","year":"2007","journal-title":"Gulf J Oncolog"},{"key":"R5-20-20241021","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/1097-0142(19830415)51:8<1393::AID-CNCR2820510812>3.0.CO;2-M","article-title":"Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence","volume":"51","author":"Perez","year":"1983","journal-title":"Cancer"},{"key":"R6-20-20241021","first-page":"010","article-title":"Evaluation of role of concurrent chemotherapy and brachytherapy in locally advanced cervical cancer patients","volume":"8","author":"Chandel","year":"2016","journal-title":"J Cancer Sci Ther"},{"key":"R8-20-20241021","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-20-20241021","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"l999","journal-title":"J Clin Onco"},{"key":"R10-20-20241021","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"R11-20-20241021","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"R12-20-20241021","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"R13-20-20241021","first-page":"RT01","article-title":"Comparison of acute toxicities and locoregional control of intracavitary brachytherapy with or without concurrent weekly cisplatin in patients of locally advanced cervical carcinoma following concurrent chemoradiation","volume":"5","author":"Mallick","year":"2019","journal-title":"Ann Int Med Den Res"},{"key":"R14-20-20241021","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0360-3016(03)00288-8","article-title":"Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Analysis of dose and fractionation schedule","volume":"56","author":"Toita","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20-20241021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0959-8049(01)00352-5","article-title":"Chemoradiotherapy for cervical cancer","volume":"38","author":"Rose","year":"2002","journal-title":"Eur J Cancer"},{"key":"R16-20-20241021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","article-title":"Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity","volume":"5","author":"Steel","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20-20241021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0360-3016(87)90015-0","article-title":"Combined treatment of radiation and cisdiamminedichloroplatinum (II): A review of experimental and clinical data","volume":"13","author":"Dewit","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20-20241021","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2307\/3574686","article-title":"Radiation-induced DNA damage and lethality in E. coli as modified by the antitumor agent cis-dichlorodiammineplatinum (II)","volume":"71","author":"Richmond","year":"1977","journal-title":"Radiat Res"},{"key":"R19-20-20241021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0360-3016(95)02088-8","article-title":"Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines","volume":"34","author":"Britten","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-20-20241021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6874-6-3","article-title":"Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results","volume":"6","author":"Cetina","year":"2006","journal-title":"BMC Womens Health"},{"key":"R21-20-20241021","first-page":"201","article-title":"Weekly cisplatin 20 mg\/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind Hospital: A randomized controlled trial","volume":"11","author":"Punushapai","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"R22-20-20241021","first-page":"45","article-title":"Concurrent chemo-brachytherapy with Cisplatin and intracavitary brachytherapy in locally advanced uterine cervical cancer","volume":"2","author":"Aghili","year":"2010","journal-title":"CANCER Bulletin Cancer Institute Iran"},{"key":"R23-20-20241021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1259\/bjr.71.845.9691902","article-title":"A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix","volume":"71","author":"Koumantakis","year":"1998","journal-title":"Br J Radiol"},{"key":"R24-20-20241021","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2004.06.248","article-title":"Concomitant chemo brachy radiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a Phase II study","volume":"61","author":"Vrdoljak","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20-20241021","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00066-002-0956-1","article-title":"Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a Phase-II study","volume":"178","author":"Strauss","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"R26-20-20241021","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0973-1482.38996","article-title":"Radical radiotherapy treatment (EBRT+HDR-ICRT) of carcinoma of the uterine cervix: Outcome in patients treated at a rural center in India","volume":"3","author":"Jain","year":"2007","journal-title":"J Cancer Res Ther"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_507_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:40:26Z","timestamp":1787067626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_507_20"}},"subtitle":["A study from rural area of Maharashtra, India"],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_507_20","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}